-
Some Hospitalized COVID-19 Patients Have Ongoing GI Symptoms
drugs
July 15, 2021
Nearly one in five patients hospitalized with COVID-19 has gastrointestinal (GI) symptoms, with persistence of symptoms in some patients for up to six months, according to a study recently published in Clinical Gastroenterology and Hepatology.
-
Galapagos demonstrates early clinical activity with SIK2/3 inhibition in inflammation
firstwordpharma
July 15, 2021
Galapagos NV(Euronext & Nasdaq: GLPG)reports topline results with GLPG3970 in three patientstudies.
-
Johnson & Johnson Single-Shot COVID-19 Vaccine Demonstrated a Durable Immune Response and Elicited Dual Mechanisms of Protection Against Delta and Other SARS-CoV-2 Variants of Concern in Data Publishe
firstwordpharma
July 15, 2021
Interim results from a Phase 1/2a sub-study published in the New England Journal of Medicine(NEJM) demonstrated that both humoral (antibody) and cellular (T-cell) immune responses generated by the Johnson & Johnson single-shot COVID-19 vaccine
-
Delivery of Pfizer jabs to be cut 10% in Osaka, Tokyo’s Setagaya, more
firstwordpharma
July 15, 2021
Japan’s government will reduce the supply of Pfizer’s COVID-19 vaccine to local governments by 10% for the first half of August if they are deemed to have an excess stock of it, The Asahi Shimbun reported.
-
NanoDx™ Announces Licensing Collaboration with IBM Research for the Design and Manufacturing of Nanoscale Sensors for Rapid Diagnostic Testing
prnewswire
July 15, 2021
NanoDx, Inc. today announced a licensing agreement with IBM Research for use of its metal-oxide semi-conductive ("CMOS") compatible nanoscale sensors to enhance and expand accurate, rapid testing for several indications
-
UC Berkeley Study Reveals Welbehealth's Rapid Adaptation To COVID-19 Eldercare Yielded Exceptional Results And Saved Lives
prnewswire
July 15, 2021
A new study from UC Berkeley's Berkeley Roundtable on the International Economy (BRIE) features WelbeHealth in a case study illustrating how this California eldercare PACE provider responded early and decisively to the COVID-19 crisis.
-
Majority (78%) Say COVID-19 Elevated Importance of Wellbeing Benefits and Support, New Welltok Survey Finds
prnewswire
July 15, 2021
Wellbeing has become a bigger priority for many Americans (78%) since the onset of the COVID-19 pandemic.
-
Europe Returns to No. 1 Destination for US Travelers for First Time Since Covid-19
prnewswire
July 15, 2021
According to travel insurance comparison site, Squaremouth.com, May marked the first month Europe regained its spot as the top destination for US tourists, with 22% of bookings.
-
Diversified Medical Healthcare Acquires RapidRona, Expanding into the Home Wellness Market
prnewswire
July 15, 2021
Diversified Medical Healthcare (DMH), has acquired RapidRona, making its foray into the home wellness testing market.
-
"Long COVID": More than a quarter of COVID-19 patients still symptomatic after 6 months
worldpharmanews
July 14, 2021
In a new study of adults from the general population who were infected with COVID-19 in 2020, more than a quarter report not having fully recovered after six to eight months.